Jonathan A. Nowak
@jonathan_nowak
Followers
404
Following
503
Statuses
222
Molecular and GI pathologist. Assoc director, BWH Center for Advanced Molecular Diagnostics. @BrighamWomens @BWHPath @DanaFarber @harvardmed Views are my own.
Boston, MA
Joined March 2016
Excited to head to ASCO GI next week to present our work on the prognostic and predictive role of ctDNA in stage III colon cancer in the 80702 clinical trial. Thanks to @ASCO for kindly considering our late-breaking abstract. @ALLIANCE_org @DanaFarber @NateraOncology #GI25
2
0
9
@DrJashDatta @SylvesterCancer @DrSDNimer @umiamimedicine @UMiamiHealth @UMiamiMedNews @JTrentMDPhD @DrOlaLandgren @JaimeMerchan10 @UMJMHSurgery @PeterHoseinMD @NbmerchantMD Congrats Jash! Very well deserved. Look forward to seeing what you accomplish.
1
0
1
RT @Aiims1742: NCT06445062: Revolution Medicines trial combining RMC-6236 with either FOLFIRINOX or Gemcitabine/nab-paclitaxel in treatment…
0
20
0
Thrilled for the Wolpin-Nowak lab to be part of the correlative science team for this cohort! An amazing opportunity to conduct great science using human specimens to rapidly improve RAS inhibitor use in PDAC.
We are excited to have launched an expanded Phase 1 trial cohort for pancreatic cancer with Revolution Medicines. This trial uses serial biopsies and blood samples to analyze tumor response to RMC-6236 at an unprecedented level of cellular detail Read more here: #PancreaticCancer#RadicalCollaboration
0
0
7
Thank you #AMPath24 Program Cmte, all our exhibitors & sponsors, speakers, attendees, volunteers, and the @AMPath team for another truly amazing meeting. Thank you #Vancouver for being such a wonderful host city. Save the dates now for #AMPath25 Boston! #beantown
0
2
9
So many opportunities to learn from long range sequencing approaches. Great perspective on the current landscape and personal experience presented by @sedlazeck @BCM_HGSC at #AMPath24. @AMPath
0
2
15
Thought provoking Solid Tumor plenary session at #AMPath24 by Peter Sorger @harvardmed on insights gained from and opportunities presented by spatial tissue profiling and ML. Also so many beautiful images. @AMPath
0
3
19
Amazing input requirements and performance characteristics for internally developed clinical WES at @DHMCandClinics pathology. @LJTafeMD at #AMPath24. @AMPath
1
3
15
Standing room only for @ColumbiaPath Dr. Susan Hsiao presenting on clinical cancer exome sequencing and transcriptome profiling for pediatric patients at #AMPath24. Amazing that her lab has been doing this work for nearly a decade. @AMPath
0
1
11
Thrilled to kick off the 30th annual AMP annual meeting in Vancouver earlier this morning! Thanks to our Program Committee members and AMP staff for putting together a great agenda for us.
0
1
9
Great start to the @break_cancer 2024 summit hosted by @MDAndersonNews in Houston! Looking forward to the next two days. #RadicalCollaboration
0
5
29
Wolpin-Nowak lab entry into the @DanaFarber pumpkin decorating contest. We started with an mIF image of the PDAC TME then used AI to render as a skull with a Dia de Los Muertos theme. Hand painted by the amazing Bridget Cahill of the Rosenthal lab. Happy Friday everyone!
4
2
35
Thank you, @ALLIANCE_org, for the recognition of our team. Large multi site trials like C80702 provide such a wealth of high impact data for patient care. Look for our ctDNA results coming early next year!
Congratulations, Cynthia Ma, MD, PhD @WashuOnc et al and @jonathan_nowak @DanaFarber et al, for receiving Honorable Mention - Most Significant Alliance Manuscripts, 2023-2024! & #AllianceFall24 #NCI #NCTN #CancerResearch
0
0
7
Thanks for highlighting our lab’s classic KRAS assay @JMDiagn! Served us well for more than a decade. Pyrosequncing traces were always such fun little puzzles. Might be dating myself, but we were still running this assay when I was an MGP fellow.
#25for25 #JMDSilver 7. Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing. Authors from @Brighamwomens, @Danafarber, @HarvardMed, @Biotage, and @MassGeneralNews. Published in 2005. Cited 454 times.
0
1
14